Elsevier

American Heart Journal

Volume 111, Issue 6, June 1986, Pages 1021-1029
American Heart Journal

A randomized controlled trial of intravenous streptokinase in evolving acute myocardial infarction

https://doi.org/10.1016/0002-8703(86)90001-3Get rights and content

Abstract

To determine the efficacy of intravenous streptokinase in acute myocardial infarction, 52 patients were randomized to intravenous streptokinase or control groups. Time from onset of infarction to randomization was similar in the streptokinase group and control group, 4.9 ± 2.1 hours vs 5.4 ± 2.4 hours, respectively. The 28 streptokinase patients received an intravenous infusion of 700,000 units of streptokinase followed by full-dose anticoagulation. The 24 control patients received normal saline solution followed by full-dose anticoagulation. Of 28 streptokinase patients, 12 (43%) had noninvasive evidence of reperfusion by early peaking of serum creatine kinase (peak creatine kinase less than 16 hours after onset of infarction) vs 3 of 24 control patients (13%), p < 0.02. Two streptokinase patients (7%) had reperfusion arrhythmias during streptokinase infusion. One streptokinase patient (4%) and two control patients (8%) died during hospitalization. At angiography (16 ± 5 days after infarction) 22 of 26 streptokinase patients (85%) had a patent infarct-related coronary artery compared to 8 of 20 control patients (40%), p < 0.01. Comparison of radionuclide left ventricular ejection fraction assessed acutely (28 ± 10 hours after infarction) with left ventricular ejection fraction at hospital discharge (15 ± 3 days after infarction) showed no significant improvement in either the streptokinase or control group, 0% and +1%, respectively. At follow-up 13 ± 7 months after infarction, total mortality rate was similar in the streptokinase group and control group, 17.8% (5 of 28 streptokinase patients) and 20.8% (5 of 24 control patients), respectively. These results indicate that the incidence of a patent infarct-related coronary artery 2 to 3 weeks after acute myocardial inf arction was significantly greater in patients who received intravenous streptokinase compared to control patients.

References (49)

  • M.E. Bertrand et al.

    Coronary arteriography in acute transmural myocardial infarction

    Am Heart J

    (1979)
  • A.D. Pichard et al.

    Angiographic study of the infarct-related coronary artery in the chronic stage of acute myocardial infarction

    Am Heart J

    (1983)
  • C.W. White et al.

    Systemic markers of fibrinolysis after unsuccessful intracoronary streptokinase thrombolysis for acute myocardial infarction. Does nonreperfusion indicate failure to achieve a systemic lytic state?

    Am J Cardiol

    (1984)
  • P. Rentrop et al.

    Changes in left ventricular function after intracoronary streptokinase infusion in clinically evolving myocardial infarction

    Am Heart J

    (1981)
  • S.G. Ellis et al.

    Time course of functional and biochemical recovery of myocardium salvaged by reperfusion

    J Am Coll Cardiol

    (1983)
  • K.P. Rentrop et al.

    Acute myocardial infarction: Intracoronary application of nitroglycerin and streptokinase

    Clin Cardiol

    (1979)
  • K.P. Rentrop et al.

    Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris

    Circulation

    (1981)
  • D.G. Mathey et al.

    Nonsurgical coronary artery recanalization in acute transmural myocardial infarction

    Circulation

    (1981)
  • J.E. Markis et al.

    Myocardial salvage after intracoronary thrombolysis with streptokinase in acute myocardial infarction

    N Engl J Med

    (1981)
  • K.A. Reduto et al.

    Intracoronary infusion of streptokinase in patients with acute myocardial infarction: Effects of reperfusion on left ventricular performance

    Am J Cardiol

    (1981)
  • J.L. Anderson et al.

    A randomized trial of Intracoronary streptokinase in the treatment of acute myocardial infarction

    N Engl J Med

    (1983)
  • F. Khaja et al.

    Intracoronary fibrinolytic therapy in acute myocardial infarction, report of a prospective randomized trial

    N Engl J Med

    (1983)
  • W.J. Kennedy et al.

    The Western Washington Intracoronary streptokinase in acute myocardial infarction randomized trial. Analysis of early mortality

    N Engl J Med

    (1983)
  • R. Schroeder et al.

    Intravenous short-term infusion of streptokinase in acute myocardial infarction

    Circulation

    (1983)
  • Cited by (0)

    View full text